Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2018

Open Access 01-12-2018 | Correction

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Authors: D. Porter, N. Frey, P. A. Wood, Y. Weng, S. A. Grupp

Published in: Journal of Hematology & Oncology | Issue 1/2018

Login to get access

Excerpt

The original article [1] contains several small errors. The errors & concurrent corrections are listed below: …
Literature
2.
go back to reference Proceedings of the Haematologica: Ferrata Storti Foundation via Giuseppe Belli 4, 27100 Pavia, Italy; 2017. Proceedings of the Haematologica: Ferrata Storti Foundation via Giuseppe Belli 4, 27100 Pavia, Italy; 2017.
3.
go back to reference Patel YB, Kantarjian HM, Thomas D, O’Brien S, Ravandi F, Garcia-Manero G, Cortes J, Konopleva M, Jain N, Garris R, Autry J, Jabbour EJ. Characterization of fever, infection, and cytokine release syndrome (CRS) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia treated with blinatumomab [abstract]. Blood. 2015;125(abstract 2530) Patel YB, Kantarjian HM, Thomas D, O’Brien S, Ravandi F, Garcia-Manero G, Cortes J, Konopleva M, Jain N, Garris R, Autry J, Jabbour EJ. Characterization of fever, infection, and cytokine release syndrome (CRS) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia treated with blinatumomab [abstract]. Blood. 2015;125(abstract 2530)
4.
go back to reference Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, investigators VASST. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87.CrossRefPubMed Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, investigators VASST. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87.CrossRefPubMed
Metadata
Title
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Authors
D. Porter
N. Frey
P. A. Wood
Y. Weng
S. A. Grupp
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2018
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/s13045-018-0627-z

Other articles of this Issue 1/2018

Journal of Hematology & Oncology 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine